Our Pricing

Understanding Mounjaro Interactions

Published on: June 03, 2026

Understanding mounjaro interactions uk is essential for safe and effective treatment with tirzepatide. At Cured Pharmacy, our UK-registered clinical team assesses every patient's medication history during consultation to identify potential interactions and ensure Mounjaro is prescribed safely alongside your existing medicines.

How Mounjaro Interacts With Other Medications

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that works by slowing gastric emptying and regulating blood glucose levels [1]. This mechanism means it can affect how quickly other oral medications are absorbed into your bloodstream, creating clinically significant interactions with certain drug classes.

The most important mounjaro drug interactions occur with diabetes medications, particularly insulin and sulphonylureas like gliclazide or glimepiride. When combined with Mounjaro, these medicines significantly increase the risk of hypoglycaemia (low blood sugar) [1]. Your UK prescriber will typically reduce doses of these medications when initiating Mounjaro treatment to maintain safe blood glucose levels.

Mounjaro also delays gastric emptying by approximately 30-40%, which can reduce the absorption rate of oral contraceptives, antibiotics, and other time-sensitive medications [2]. This doesn't necessarily mean you cannot take these medicines together, but timing and monitoring become crucial considerations your prescriber will address during consultation.

Medications to Avoid With Mounjaro

Whilst Mounjaro has relatively few absolute contraindications, certain medications require careful management or dose adjustments when prescribed together. Insulin and insulin secretagogues (sulphonylureas and meglitinides) present the highest interaction risk due to additive glucose-lowering effects [1].

Other GLP-1 receptor agonists should never be combined with Mounjaro, as this provides no additional benefit and substantially increases the risk of gastrointestinal side effects and hypoglycaemia. This includes medications like Wegovy, Saxenda, Ozempic, Victoza, and Trulicity [3].

Warfarin users require additional monitoring when starting Mounjaro, as changes in dietary intake and body weight can affect INR levels. Your anticoagulation clinic should be informed if you begin tirzepatide treatment so monitoring frequency can be adjusted appropriately [2].

Oral Contraceptive Considerations

Women taking oral contraceptives should be aware that Mounjaro's effect on gastric emptying may reduce contraceptive absorption, particularly during the first four weeks of treatment when gastrointestinal effects are most pronounced [2]. The MHRA advises using additional barrier contraception during this period and for four weeks after any dose increase to ensure contraceptive efficacy is maintained.

Mounjaro and Diabetes Medications

The interaction between Mounjaro and other diabetes medications requires particularly careful management by your UK prescriber. In the SURPASS-3 trial, participants taking background insulin required an average 47% reduction in their insulin dose when tirzepatide was introduced to maintain target glucose levels without hypoglycaemia [1].

Metformin can generally be continued safely alongside Mounjaro without dose adjustment, as the two medications work through different mechanisms and do not significantly increase hypoglycaemia risk when combined [1]. Many prescribers continue metformin during Mounjaro treatment to provide complementary glucose control.

SGLT2 inhibitors (such as dapagliflozin, empagliflozin, or canagliflozin) can typically be used with Mounjaro, though your prescriber will monitor for dehydration risk, particularly if you experience gastrointestinal side effects during treatment initiation [3].

Insulin Dose Adjustments

If you currently use insulin, your prescriber will implement a structured dose reduction protocol when starting Mounjaro. Basal insulin doses are typically reduced by 20-30% initially, with further adjustments based on your glucose monitoring data [1]. This careful titration prevents hypoglycaemia whilst allowing Mounjaro to demonstrate its glucose-lowering effect.

Mounjaro Interactions With Common Medicines

Paracetamol and most over-the-counter pain relievers can be taken safely with Mounjaro without dose adjustment. However, NSAIDs like ibuprofen should be used cautiously if you experience nausea or vomiting, as dehydration can increase the risk of kidney complications with these medications [2].

Antibiotics can be prescribed alongside Mounjaro, though your prescriber may advise taking them at least one hour before or four hours after your Mounjaro injection to optimise absorption [2]. This timing consideration is particularly important for antibiotics requiring consistent blood levels, such as fluoroquinolones or tetracyclines.

Statins, blood pressure medications (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers), and thyroid medications can all be continued safely with Mounjaro. The weight loss achieved with tirzepatide may actually improve the effectiveness of blood pressure medications, occasionally requiring dose reductions as treatment progresses [3].

Alcohol and Mounjaro Safety

Whilst alcohol is not strictly contraindicated with Mounjaro, it does increase the risk of several complications. Alcohol consumption can potentiate hypoglycaemia risk, particularly if you're also taking insulin or sulphonylureas alongside tirzepatide [1].

The gastrointestinal side effects commonly experienced with Mounjaro—nausea, vomiting, and diarrhoea—can be significantly worsened by alcohol consumption. Many patients find that alcohol tolerance decreases during Mounjaro treatment, with smaller amounts producing more pronounced effects [3].

If you choose to drink alcohol whilst taking Mounjaro, limit consumption to moderate amounts (no more than 14 units weekly, spread across several days), always consume with food, and monitor your blood glucose more frequently if you have diabetes. Avoid alcohol entirely if you experience persistent gastrointestinal symptoms.

Pancreatitis Risk Considerations

Heavy alcohol consumption is a known risk factor for pancreatitis, and GLP-1 receptor agonists including Mounjaro carry a small increased risk of this serious condition [4]. The combination of alcohol and tirzepatide may theoretically compound this risk, though clinical data remains limited. If you develop severe abdominal pain radiating to your back, stop Mounjaro immediately and seek urgent medical attention.

How Cured Pharmacy Manages Mounjaro Interactions

Every patient requesting Mounjaro from Cured Pharmacy completes a comprehensive medication history during their free online consultation. Our UK-registered prescribers review all current medications, supplements, and over-the-counter products to identify potential interactions before prescribing tirzepatide.

When clinically significant interactions are identified, our prescribers provide specific guidance on timing adjustments, dose modifications, or monitoring requirements. For complex medication regimens, particularly in patients with diabetes taking multiple glucose-lowering agents, our superintendent pharmacist Tarun Kumar (GPhC 2233073) may conduct an additional medication review to ensure safe prescribing.

Mounjaro is available from Cured Pharmacy from £124.99, with all prices displayed transparently before consultation. Your prescribed dose depends on your individual assessment, current medications, and treatment response. All Mounjaro prescriptions are dispensed with detailed patient information leaflets covering interactions, and our pharmacy team remains available on (+44) 116 4646009 for any medication queries during your treatment.

Scientific References

1. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. UK Government. Retrieved from https://www.gov.uk/ [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Azoulay, L., Filion, K. B., Platt, R. W., et al. (2016). Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Internal Medicine, 176(10), 1464-1473. https://doi.org/10.1001/jamainternmed.2016.1522 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience any adverse drug interactions or unexpected symptoms whilst taking Mounjaro, stop the medication and seek immediate medical attention.